News | Population Health | January 10, 2019

Mobile App Data Collection Shows Promise for Population Health Surveys

Researchers evaluate Medable Inc.’s mobile health survey solution as potential way to eliminate barriers to large-scale data collection

Mobile App Data Collection Shows Promise for Population Health Surveys

January 10, 2019 — Mobile app data collection can bring access to more potential clinical study participants, reduce clinical study timeframes and create more comprehensive sample sizes, according to research published in Survey Practice.1

“It is critical that health and other national surveys represent the voice and experience of all Americans,” said senior author Ingrid Oakley-Girvan, senior vice president of research and strategy at Medable Inc., research director at the Public Health Institute, and associate member of the Canary Center at Stanford for Cancer Early Detection and the Stanford Cancer Institute. “Smartphone survey data can help policy makers allocate resources in realtime to respond to disease outbreaks such as opioid addiction. Our work sheds light on the value of smartphones to address declining participation rates, rising survey costs and poor coverage across demographics.”

Oakley-Girvan and co-authors Yasamin Miller, Cyrus DiCiccio, Juan Lavista, Cheryl Gore-Felton, Amanda Richardson, Carlos Acle, Jeff Hancock, Lorene Nelson and Oxana Palesh were interested in the impact that smartphones can have on health data survey collection.

They studied the response to a mobile app survey, built on the Medable Inc. platform, by deploying it in a college student population to determine if students would download the app, and to determine if the app would retain individuals in a study, two significant barriers being faced by researchers conducting population health surveys.  

“Our findings show that mobile app data collection can fundamentally change survey research,” said Miller, first author and founder and managing director of YMG. “Using mobile apps could create a shift in health surveys, which could eventually lead to faster and more accurate health policies and cures.”

Declining response rates to traditional telephone surveys are hindering researchers in their abilities to recruit and study the most pressing medical issues. The study used Medable Inc.’s platform to provide efficient real-world data collection, monitoring and analysis.

The researchers partnered with faculty from Stanford University, the Cancer Prevention Institute of California (CPIC), OneTree, YMG and Castleton University, to leverage Medable’s platform to collect behavioral health and substance use data. The researchers built and deployed two apps in under six weeks.

Medable’s end-to-end (E2E) platform enables researchers without developer expertise to create and deploy HIPAA-compliant iOS and Android apps for clinical trials or research studies. “Creating mobile applications on a short timeline would not have been possible without the use of Medable’s Axon,” said Miller. “Medable’s platform enabled team members without coding expertise to contribute and play key roles in developing the study.”

For more information: www.medable.com

Reference

1. Miller Y., DiCiccio C., Lavista J., et al. Smart(phone) Approaches to Mobile App Data Collection. Survey Practice, Dec. 3, 2018. DOI: 10.29115/SP-2018-0030

Related Content

News | Contrast Media | September 03, 2019
Researchers in South Korea have found that patients with family and personal history of allergic reactions to contrast...
An example of a treatment plan for radio-ablation of the heart to noninvasively treat cardiac arrhythmias. This concept is one of the key presentations at the 2019 ASTRO meeting. Image courtesy of Cyberheart. #ASTRO19 #ASTRO2019 #ASTRO

An example of a treatment plan for radio-ablation of the heart to noninvasively treat cardiac arrhythmias. This concept is one of the key presentations at the 2019 ASTRO meeting. Image courtesy of Cyberheart.

Feature | ASTRO | August 29, 2019
FDA Encourages Inclusion of Male Patients in Breast Cancer Clinical Trials
News | Women's Health | August 26, 2019
The U.S. Food and Drug Administration (FDA) released a new draft guidance that encourages including male patients in...
Moffitt Researchers Develop Model to Personalize Breast Cancer Radiation Treatment
News | Radiation Therapy | August 26, 2019
A personalized approach to cancer treatment has become more common over the last several decades, with numerous...
Vaping Impairs Vascular Function

Image courtesy of the American Heart Association

News | Magnetic Resonance Imaging (MRI) | August 21, 2019
Inhaling a vaporized liquid solution through an e-cigarette, otherwise known as vaping, immediately impacts vascular...
Some Pregnant Women Are Exposed to Gadolinium in Early Pregnancy
News | Women's Health | August 20, 2019
A small but concerning number of women are exposed to a commonly used magnetic resonance imaging (MRI) contrast agent...
ADHD Medication May Affect Brain Development in Children

Images of regions of interest (colored lines) in the white matter skeleton representation. Data from left and right anterior thalamic radiation (ATR) were averaged. Image courtesy of C. Bouziane et al.

News | Neuro Imaging | August 16, 2019
A drug used to treat attention-deficit/hyperactivity disorder (ADHD) appears to affect development of the brain’s...
First Patient Enrolled in World's Largest Brain Cancer Clinical Trial
News | Radiation Therapy | August 15, 2019
Henry Ford Cancer Institute is first-in-the-world to enroll a glioblastoma patient in the GBM AGILE Trial (Adaptive...